CardioSideral Heart Surgery: Randomized Study on Sucrosomial Iron Supplementation Before Heart Surgery

CardioSideral Heart Surgery: Randomized Study on Sucrosomial Iron Supplementation

This randomized, single blind (Outcomes Assessor), non-profit study is aimed at verifying whether routine preoperative supplementation with Sucrosomial® Iron in patients scheduled for cardiac surgery may increase baseline haemoglobin, constrain the haemoglobin decrease between postoperative day 2 and 3 (haemoglobin drift), and reduce the postoperative transfusion requirements, in order to identify a new strategy for pre-hospitalization optimization and post-operative recovery.

This randomized, single blind (Outcomes Assessor), non-profit study is aimed at verifying whether routine preoperative supplementation with Sucrosomial® Iron in patients scheduled for cardiac surgery may increase baseline haemoglobin, constrain the haemoglobin decrease between postoperative day 2 and 3 (haemoglobin drift), and reduce the postoperative transfusion requirements, in order to identify a new strategy for pre-hospitalization optimization and post-operative recovery.

Secondary Objectives are

• Changes in blood chemistry and biochemical tests between pre- and post-intervention
• Evaluation of tolerability and compliance of supplementation with Sucrosomal Iron
• Reduction in the number of transfusions and blood bags used
• Evaluation of cost-effectiveness

Inclusion Criteria:

Undergoing elective Heart Surgery -

Exclusion Criteria:

- Emergent or Urgent Indication